Insulet | Себестоимость



Cost Of Sales Изменить Дата
Abbott USD 4.44B 502M 2025-03
Align Technology USD 299.15M 876K 2025-03
AtriCure USD 30.99M 666K 2025-03
Avanos Medical USD 77.7M 3.9M 2025-03
Baxter International USD 1.74B 73M 2024-12
Becton, Dickinson and Co. USD 3.02B 82M 2025-03
Boston Scientific USD 1.47B 5M 2025-03
Cardinal Health USD 52.76B 568M 2025-03
Cooper Companies USD 323.2M 18.7M 2025-04
Dexcom USD 447M 42.8M 2025-03
Edwards Lifesciences USD 301.6M 9.4M 2025-03
Eli Lilly USD 2.22B 179.6M 2025-03
Globus Medical USD 195.4M 68.04M 2025-03
ICU Medical USD 394.59M 7.95M 2025-03
Insulet USD 160M 6.6M 2025-03
Integra LifeSciences USD 167.51M 9.29M 2025-03
J&J USD 7.3B 189M 2025-03
Masimo USD 138M 218M 2025-03
Medtronic USD 3.11B 339M 2025-04
Merit Medical Systems USD 733.32M 551.15M 2025-03
Roche Holding CHF 4.13B 393.5M 2024-12
Solventum Corp 946M 9M 2025-03
Stryker USD 2.12B 118M 2025-03
Tandem Diabetes Care USD 116.02M 9.18M 2025-03
Teleflex USD 311.23M 44.26M 2025-03
West Pharmaceutical Services USD 466.1M 9.1M 2025-03
Zimmer Biomet Holdings USD 586.7M 48.1M 2024-12



Insulet Себестоимость - Текущие значения, предыдущие значения, прогнозы, графики и экономический календарь - Jul 2025.